Icahn School of Medicine at Mount Sinai
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Liver transplant participants will be recruited. Participants will wear a blinded sensor after hospital discharge for up to 30 days. Data can be shared with participant and the providers retrospectively. Participants will be invited to wear another blinded sensor at 6 and 12 months.
Inclusion Criteria: • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL Exclusion Criteria: * having a planned discharge to a rehabilitation or nursing facility, * a contraindication to sensor placement, * if discharge is anticipated to be \>30 days post-transplant, or * if recent transplant also included a kidney or pancreas transplant
Blinded CGM will be worn by all participants
Verify or correct the compensation shown for this listing.